Behavioral interventions may prolong remission in patients with inflammatory bowel disease

Laurie Keefer*, Jennifer L. Kiebles, Zoran Martinovich, Elyse Cohen, Alyssa Van Denburg, Terrence A. Barrett

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


Inflammatory Bowel Diseases (IBDs) are chronic, relapsing and remitting gastrointestinal conditions with no known cure. Previous studies have linked behavioral factors, including stress and medication adherence, to relapse. Purpose: We sought to determine the effect of participation in a behavioral self-management program on incidence of flare within 12 months following behavioral intervention when compared to the natural history of flare incidence prior to program participation. Results: Results from a 2-level regression model indicated that those participants in the treatment group were 57% less likely to flare in the following 12 months (compared to 18% in the control group). The decline in "flare odds" was about 2 times greater in treatment versus controls (OR. = 0.52, t(34). = 2.07, p<0.05). Office visits, ER visits, and disease severity (all p<0.05) were identified as moderators of flare risk. Conclusions: We have demonstrated 1) a statistical model estimating the likelihood of flare rates in the 12 months following a behavioral intervention for IBD (compared to a control condition), and 2) that the introduction of a behavioral intervention can alter the natural course of a chronic, relapsing and remitting gastrointestinal condition such as IBD.

Original languageEnglish (US)
Pages (from-to)145-150
Number of pages6
JournalBehaviour Research and Therapy
Issue number3
StatePublished - Mar 2011


  • Behavioral self-management
  • Crohn's disease
  • Hypnotherapy
  • IBD
  • Remission
  • Ulcerative colitis

ASJC Scopus subject areas

  • Experimental and Cognitive Psychology
  • Psychiatry and Mental health
  • Clinical Psychology


Dive into the research topics of 'Behavioral interventions may prolong remission in patients with inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this